AAAAAA

   
Results: 1-24 |
Results: 24
ZERO EXPOSURE - AN ALTERNATIVE APPROACH TO HEALTH-BASED RISK ASSESSMENT
Authors: RAVAL P
Citation: P. Raval, ZERO EXPOSURE - AN ALTERNATIVE APPROACH TO HEALTH-BASED RISK ASSESSMENT, Ground water monitoring & remediation, 18(1), 1998, pp. 69-70
TIGHT BLOOD-PRESSURE CONTROL AND RISK OF MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE-2 DIABETES - UKPDS 38
Authors: STEARNE MR PALMER SL HAMMERSLEY MS FRANKLIN SL SPIVEY RS LEVY JC TIDY CR BELL NJ STEEMSON J BARROW BA COSTER R WARING K NOLAN J TRUSCOTT E WALRAVENS N COOK L LAMPARD H MERLE C PARKER P MCVITTIE J DRAISEY I MURCHISON LE BRUNT AHE WILLIAMS MJ PEARSON DW PETRIE XMP LEAN MEJ WALMSLEY D LYALL MJ CHRISTIE E CHURCH J THOMSON E FARROW A STOWERS JM STOWERS M MCHARDY K PATTERSON N WRIGHT AD LEVI NA SHEARER ACI THOMPSON RJW TAYLOR G RAYTON S BRADBURY M GLOVER A SMYTHOSBOURNE A PARKES C GRAHAM J ENGLAND P GYDE S EAGLE C CHAKRABARTI B SMITH J SHERWELL J KOHNER EM DORNHURST A DODDRIDGE MC DUMSKYJ M WALJI S SHARP P SLEIGHTHOLM M VANTERPOOL G ROSE C FROST G ROSEBLADE M ELLIOTT S FORRESTER S FOSTER M MYERS K CHAPMAN R HAYES JR HENRY RW FEATHERSTON MS ARCHBOLD GPR COPELAND M HARPER R RICHARDSON I MARTIN S FOSTER M DAVISON HA HADDEN DR KENNEDY L ATKINSON AB CULBERT AM HEGAN C TENNET H WEBB N ROBINSON I HOLMES J FOSTER M BELL PM MCCANCE DR RUTHERFORD J NESBITT S SPATHIS AS HYER S NANSON ME JAMES LM TYRELL JM DAVIS C STRUGNELL P BOOTH M PETRIE H CLARK D RICE B HULLAND S BARRON JL YUDKIN JS GOULD BJ SINGER J BADENOCK A WALJI S ECKERT M ALIBHAI K MARRIOT E COX C PRICE R FERNANDEZ M RYLE A CLARKE S WALLACE G MEHMED E MACFARLANE S GREENWOOD RH WILSON J DENHOLM MJ TEMPLE RC WHITFIELD K JOHNSON F MUNROE C GORICK S DUCKWORTH E FLATMAN M RAINBOW S BORTHWICK LJ WHEATCROFT DJ SEAMAN RJ CHRISTIE RA WHEATCROFT W MUSK P WHITE J MCDOUGAL S BOND M RANIGA P NEWTON RW JUNG RT ROXBURGH C KILGALLON B DICK L FOSTER M WAUGH N KILBY S ELLINGFORD A BURNS J FOX CV HOLLOWAY MC COGHILL HM HEIN N FOX A COWAN W RICHARD M QUESTED K EVANS SJ PAISEY RB BROWN NPR TUCKER AJ PAISEY R GARRETT F HOGG J PARK P WILLIAMS K HARVEY P WILCOCKS R MASON S FROST J WARREN C ROCKET P BOWER L ROLAND JM BROWN DJ YOUENS J STANTONKING K MUNGALL H BALL V MADDISON W DONNELLY D KING S GRIFFIN P SMITH S CHURCH S DUNN G WILSON A PALMER K BROWN PM HUMPHRISS D DAVIDSON AJM ROSE R ARMISTEAD L TOWNSEND S POON P PEACOCK IDA CULVERWELL NJC CHARLTON MH CONNOLLY BPS PEACOCK J BARRETT J WAIN J BEESTON W KING G HILL PG BOULTON AJM ROBERTSON AM KATOULIS V OLUKOGA A MCDONALD H KUMAR S ABOUAESHA F ABUAISHA B KNOWLES EA HIGGINS S BOOKER J SUNTER J BREISLIN K PARKER R RAVAL P CURWELL J DAVENPORT H SHAWCROSS G PREST A GREY J COLE H SEREVIRATNE C YOUNG RJ DORNAN TL CLYNE JR GIBSON M OCONNELL I WONG LM WILSON SJ WRIGHT KL WALLACE C MCDOWELL D BURDEN AC SELLEN EM GREGORY R ROSHAN M VAGHELA N BURDEN M SHERRIFF C CLARKE J GRENFELL J TOOKE JE MACLEOD K SEARNARK C RAMMELL M PYM C STOCKMAN J YEO C PIPER J LEIGHTON L GREEN E HOYLE M JONES K HUDSON A JAMES AJ SHORE A HIGHAM A MARTIN B
Citation: Mr. Stearne et al., TIGHT BLOOD-PRESSURE CONTROL AND RISK OF MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE-2 DIABETES - UKPDS 38, BMJ. British medical journal, 317(7160), 1998, pp. 703-713
EFFICACY OF ATENOLOL AND CAPTOPRIL IN REDUCING RISK OF MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE-2 DIABETES - UKPDS-39
Authors: STEARNE MR PALMER SL HAMMERSLEY MS FRANKLIN SL SPIVEY RS LEVY JC TIDY CR BELL NJ STEEMSON J BARROW BA COSTER R WARING K NOLAN L TRUSCOTT E WALRAVENS N COOK BL LAMPARD H MERLE C PARKER P MCVITTIE J DRAISEY I MURCHISON LE BRUNT AHE WILLIAMS MJ PEARSON DW PETRIE XMP LEAN MEJ WALMSLEY D LYALL F CHRISTIE E CHURCH J THOMSON E FARROW A STOWERS JM STOWERS M MCHARDY K PATTERSON N WRIGHT AD LEVI NA SHEARER AGI THOMPSON RJW TAYLOR G RAYTON S BRADBURY M GLOVER A SMYTHOSBOURNE A PARKES C GRAHAM J ENGLAND P GYDE S EAGLE C CHAKRABARTI B SMITH J SHERWELL J KOHNER EM DORNHORST A DODDRIDGE MC DUMSKYJ M WALJI S SHARP P SLEIGHTHOLM M VANTERPOOL G ROSE C FROST G ROSEBLADE M ELLIOTT S FORRESTER S FOSTER M MYERS K CHAPMAN R HAYES JR HENRY TW FEATHERSTON MS ARCHBOLD GPR COPELAND M HARPER R RICHARDSON I MARTIN S FOSTER M DAVISON HA HADDEN DR KENNEDY L ATKINSON AB CULBERT AM HEGAN C TENNET H WEBB N ROBINSON I HOLMES J FOSTER M BELL PM MCCANCE DR RUTHERFORD J NESBITT S SPATHIS AS HYER S NANSON ME JAMES JM TYRELL JM DAVIS C STRUGNELL P BOOTH M PETRIE H CLARK D RICE B HULLAND S BARRON JL YUDKIN JS GOULD BJ SINGER J BADENOCK A WALJI S ECKERT M ALIBHAI K MARRIOT E COX C PRICE R FERNANDEZ M RYLE A CLARKE S WALLACE G MEHMED E MACFARLANE S GREENWOOD RH WILSON J DENHOLM MJ TEMPLE RC WHITFIELD K JOHNSON F MUNROE C GORICK S DUCKWORTH E FLATMAN M RAINBOW S BORTHWICK LJ WHEATCROFT DJ SEAMAN RJ CHRISTIE RA WHEATCROFT W MUSK P WHITE J MCDOUGAL S BOND M RANIGA P NEWTON RW JUNG RT ROXBURGH C KILGALLON B DICK L FOSTER M WAUGH N KILBY S ELLINGFORD A BURNS J FOX CV HOLLOWAY MC COGHILL HM HEIN N FOX A COWAN W RICHARD M QUESTED K EVANS SJ PAISEY RB BROWN NPR TUCKER AJ PAISEY R GARRETT F HOGG J PARK P WILLIAMS K HARVEY P WILCOCKS R MASON S FROST J WARREN C ROCKET P BOWER L ROLAND JM BROWN DJ YOUENS J STANTONKING K MUNGALL H BALL V MADDISON W DONNELLY D KING S GRIFFIN P SMITH S CHURCH S DUNN G WILSON A PALMER K BROWN PM HUMPHRISS D DAVIDSON AJM ROSE R ARMISTEAD L TOWNSEND S POON P PEACOCK IDA CULVERWELL NJC CHARLTON MH CONNOLLY BPS PEACOCK J BARRETT J WAIN J BEESTON W KING G HILL PG BOULTON AJM ROBERTSON AM KATOULIS V OLUKOGA A MCDONALD H KUMAR S ABOUAESHA F ABUAISHA B KNOWLES EA HIGGINS S BOOKER J SUNTER J BREISLIN K PARKER R RAVAL P CURWELL J DAVENPORT H SHAWCROSS G PREST A GREY J COLE H SEREVIRATNE C YOUNG RJ DORNAN TL CLYNE JR GIBSON M OCONNELL I WONG LM WILSON SJ WRIGHT KL WALLACE C MCDOWELL D BURDEN AC SELLEN EM GREGORY R ROSHAN M VAGHELA N BURDEN M SHERRIFF C CLARKE J GRENFELL J TOOKE JE MACLEOD K SEARNARK C RAMMELL M PYM C STOCKMAN J YEO C PIPER J LEIGHTON L GREEN E HOYLE M JONES K HUDSON A JAMES AJ SHORE A HIGHAM A MARTIN B
Citation: Mr. Stearne et al., EFFICACY OF ATENOLOL AND CAPTOPRIL IN REDUCING RISK OF MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE-2 DIABETES - UKPDS-39, BMJ. British medical journal, 317(7160), 1998, pp. 713-720
COST-EFFECTIVENESS ANALYSIS OF IMPROVED BLOOD-PRESSURE CONTROL IN HYPERTENSIVE PATIENTS WITH TYPE-2 DIABETES - UKPDS-40
Authors: STEARNE MR PALMER SL HAMMERSLEY MS FRANKLIN SL SPIVEY RS LEVY JC TIDY CR BELL NJ STEEMSON J BARROW BA COSTER R WARING K NOLAN L TRUSCOTT E WALRAVENS N COOK L LAMPARD H MERLE C PARKER P MCVITTIE J DRAISEY I MURCHISON LE BRUNT AHE WILLIAMS MJ PEARSON DW PETRIE XMP LEAN MEJ WALMSLEY D LYALL F CHRISTIE E CHURCH J THOMSON E FARROW A STOWERS JM STOWERS M MCHARDY K PATTERSON N WRIGHT AD LEVI NA SHEARER ACI THOMPSON RJW TAYLOR G RAYTON S BRADBURY M GLOVER A SMYTHOSBOURNE A PARKES C GRAHAM J ENGLAND P GYDE S EAGLE C CHAKRABARTI B SMITH J SHERWELL J KOHNER EM DORNHORST A DODDRIDGE MC DUMSKYJ M WALJI S SHARP P SLEIGHTHOLM M VANTERPOOL G ROSE C FROST G ROSEBLADE M ELLIOTT S FORRESTER S FOSTER M MYERS K CHAPMAN R HAYES JR HENRY RW FEATHERSTON MS ARCHBOLD GPR COPELAND M HARPER R RICHARDSON I MARTIN S FOSTER M DAVISON HA HADDEN DR KENNEDY L ATKINSON AB CULBERT AM HEGAN C TENNET H WEBB N ROBINSON I HOLMES J FOSTER M BELL PM MCCANCE DR RUTHERFORD J NESBITT S SPATHIS AS HYER S NANSON ME JAMES LM TYRELL JM DAVIS C STRUGNELL P BOOTH M PETRIE H CLARK D RICE B HULLAND S BARRON JL YUDKIN JS GOULD BJ SINGER J BADENOCK A WALJI S ECKERT M ALIBHAI K MARRIOT E COX C PRICE R FERNANDEZ M RYLE A CLARKE S WALLACE G MEHMED E MACFARLANE S GREENWOOD RH WILSON J DENHOLM MJ TEMPLE RC WHITFIELD K JOHNSON F MUNROE C GORICK S DUCKWORTH E FLATMAN M RAINBOW S BORTHWICK LJ WHEATCROFT DJ SEAMAN RJ CHRISTIE RA WHEATCROFT W MUSK P WHITE J MCDOUGAL S BOND M RANIGA P NEWTON RW JUNG RT ROXBURGH C KILGALLON B DICK L FOSTER M WAUGH N KILBY S ELLINGTON A BURNS J FOX CV HOLLOWAY MC COGHILL HM HEIN N FOX A COWAN W RICHARD M QUESTED K EVANS SJ PAISEY RB BROWN NPR TUCKER AJ PAISEY R GARRETT F HOGG J PARK P WILLIAMS K HARVEY P WILCOCKS R MASON S FROST J WARREN C ROCKET P BOWER L ROLAND JM BROWN DJ YOUENS J STANTONKING K MUNGALL H BALL V MADDISON W DONNELLY D KING S GRIFFIN P SMITH S CHURCH S DUNN G WILSON A PALMER K BROWN PM HUMPHRISS D DAVIDSON AJM ROSE R ARMISTEAD L TOWNSEND S POON P PEACOCK IDA CULVERWELL NJC CHARLTON MH CONNOLLY BPS PEACOCK J BARRETT J WAIN J BEESTON W KING G HILL PG BOULTON AJM ROBERTSON AM KATOULIS V OLUKOGA A MCDONALD H KUMAR S ABOUAESHA F ABUAISHA B KNOWLES EA HIGGINS S BOOKER J SUNTER J BREISLIN K PARKER R RAVAL P CURWELL J DAVENPORT J SHAWCROSS G PREST A GREY J COLE H SEREVIRATNE C YOUNG RJ DORNAN TL CLYNE JR GIBSON M OCONNELL I WONG LM WILSON SJ WRIGHT KL WALLACE C MCDOWELL D BURDEN AC SELLEN EM GREGORY R ROSHAN M VAGHELA N BURDEN M SHERRIFF C CLARKE J GRENFELL J TOOKE JE MACLEOD K SEARNARK C RAMMELL M PYM C STOCKMAN J YEO C PIPER J LEIGHTON L GREEN E HOYLE M JONES K HUDSON A JAMES AJ SHORE A HIGHAM A MARTIN B
Citation: Mr. Stearne et al., COST-EFFECTIVENESS ANALYSIS OF IMPROVED BLOOD-PRESSURE CONTROL IN HYPERTENSIVE PATIENTS WITH TYPE-2 DIABETES - UKPDS-40, BMJ. British medical journal, 317(7160), 1998, pp. 720-726
EFFECTS OF THE NOVEL HIGH-AFFINITY 5-HT1B 1D-RECEPTOR LIGAND FROVATRIPTAN IN HUMAN ISOLATED BASILAR AND CORONARY-ARTERIES/
Authors: PARSONS AA RAVAL P SMITH S TILFORD N KING FD KAUMANN AJ HUNTER J
Citation: Aa. Parsons et al., EFFECTS OF THE NOVEL HIGH-AFFINITY 5-HT1B 1D-RECEPTOR LIGAND FROVATRIPTAN IN HUMAN ISOLATED BASILAR AND CORONARY-ARTERIES/, Journal of cardiovascular pharmacology, 32(2), 1998, pp. 220-224
INTENSIVE BLOOD-GLUCOSE CONTROL WITH SULFONYLUREAS OR INSULIN COMPARED WITH CONVENTIONAL TREATMENT AND RISK OF COMPLICATIONS IN PATIENTS WITH TYPE-2 DIABETES (UKPDS-33)
Authors: TURNER RC HOLMAN RR CULL CA STRATTON IM MATTHEWS DR FRIGHI V MANLEY SE NEIL A MCELROY K WRIGHT D KOHNER E FOX C HADDEN D MEHTA Z SMITH A NUGENT Z PETO R ADLEL AI MANN JI BASSETT PA OAKES SF DORNAN TL ALDINGTON S LIPINSKI H COLLUM R HARRISON K MACINTYRE C SKINNER S MORTEMORE A NELSON D COCKLEY S LEVIEN S BODSWORTH L WILLOX R BIGGS T DOVE S BEATTIE E GRADWELL M STAPLES S LAM R TAYLOR F LEUNG L CARTER RD BROWNLEE SM FISHER KE ISLAM K JELFS R WILLIAMS PA WILLIAMS FA SUTTON PJ AYRES A LOGIE LJ LOVATT C EVANS MA STOWELL LA ROSS I KENNEDY IA CROFT D KEEN AH ROSE C RAIKOU M FLETCHER AE BULPITT C BATTERSBY C YUDKIN JS STEVENS R STEARN MR PALMER SL HAMMERSLEY MS FRANKLIN SL SPIVEY RS LEVY JC TIDY CR BELL NJ STEEMSON J BARROW BA COSTER R WARING K NOLAN L TRUSCOTT E WALRAVENS N COOK L LAMPARD H MERLE C PARKER P MCVITTIE J DRAISEY I MURCHISON LE BRUNT AHE WILLIAMS MJ PEARSON DW PETRIE XMP LEAN MEJ WALMSLEY D LYALL F CHRISTIE E CHURCH J THOMSON E FARROW A STOWERS JM STOWERS M MCHARDY K PATTERSON N WRIGHT AD LEVI NA SHEARER ACI THOMPSON RJW TAYLOR G RAYTON S BRADBURY M GLOVER A SMYTHOSBOURNE A PARKES C GRAHAM J ENGLAND P GYDE S EAGLE C CHAKRABARTI B SMITH J SHERWELL J OAKLEY NW WHITEHEAD MA HOLLIER GP PILKINGTON T SIMPSON J ANDERSON M MARTIN S KEAN J RICE B ROLLAND A NISBET J KOHNER EM DORNHORST A DODDRIDGE MC DUMSKYIJ M WALJI S SHARP P SLEIGHTHOLM M VANTERPOOL G FROST G ROSEBLADE M ELLIOTT S FORRESTER S FOSTER M MYERS K CHAPMAN R HAYES JR HENRY RW FEATHERSTON MS ARCHBOLD GPR COPELAND M HARPER R RICHARDSON I DAVISON HA ALEXANDER L SCARPELLO JHB SHIERS DE TUCKER RJ WORTHINGTON JRH ANGRIS S BATES A WALTON J TEASDALE M BROWNE J STANLEY S DAVIS BA STRANGE RC HADDEN DR KENNEDY L ATKINSON AB BELL PM MCCANCE DR RUTHERFORD J CULBERT AM HEGAN C TENNET H WEBB N ROBINSON I HOLMES J NESBITT S SPATHIS AS HYER S NANSON ME JAMES LM TYRELL JM DAVIS C STRUGNELL P BOOTH M PETRIE H CLARK D HULLAND S BARRON JL GOULD BC SINGER J BADENOCH A MCGREGOR M ISENBERG L ECKERT M ALIBHAI K MARRIOT E COX C PRICE R FERNANDEZ M RYLE A CLARKE S WALLACE G MEHMED E LANKESTER JA HOWARD E WAITE A MACFARLANE S GREENWOOD RH WILSON J DENHOLM MJ TEMPLE RC WHITFIELD K JOHNSON F MUNROE C GORICK S DUCKWORTH E FATMAN M RAINBOW S BORTHWICK L WHEATCROFT DJ SEAMAN RJ CHRISTIE RA WHEATCROFT W MUSK P WHITE J MCDOUGAL S BOND M RANIGA P DAY JL DOSHI MJ WILSON JG HOWARDWILLIAMS JR HUMPHREYS H GRAHAM A HICKS K HEXMAN S BAYLISS P PLEDGER D NEWTON RW JUNG RT ROXBURGH C KILGALLON B DICK L WAUGH N KILBY S ELLINGFORD A BURNS J FOX CV HOLLOWAY MC COGHILL HM HEIN N FOX A COWAN W RICHARD M QUESTED K EVANS SJ PAISEY RB BROWN NPR TUCKER AJ PAISEY R GARRETT F HOGG J PARK P WILLIAMS K HARVEY P WILCOCKS R MASON S FROST J WARREN C ROCKET P BOWER L ROLAND JM BROWN DJ YOUENS J STANTONKING K MUNGALL H BALL V MADDISON W DONNELLY D KING S GRIFFIN P SMITH S CHURCH S DUNN G WILSON A PALMER K BROWN PM HUMPHRISS D DAVIDSON AJM ROSE R ARMISTEAD L TOWNSEND S POON P PEACOCK IDA CULVERWELL NJC CHARLTON MH CONNOLLY BPS PEACOCK J BARRETT J WAIN J BEESTON W KING G HILL PG BOULTON AJM ROBERTSON AM KATOULIS V OLUKOGA A MCDONALD H KUMAR S ABOUAESHA F ABUAISHA B KNOWLES EA HIGGINS S BOOKER J SUNTER J BREISLIN K PARKER R RAVAL P CURWELL J DAVENPORT H SHAWCROSS G PREST A GREY J COLE H SEREVIRATNE C YOUNG RJ CLYNE JR GIBSON M OCONNELL I WONG LM WILSON SJ WRIGHT KL WALLACE C MCDOWELL D BURDEN AC SELLEN EM GREGORY R ROSHAN M VAGHELA N BURDEN M SHERRIFF C MANSINGH S CLARKE J GRENFELL J TOOKE JE MACLEOD K SEAMARK C RAMMELL M PYM C STOCKMAN J YEO C PIPER J LEIGHTON L GREEN E HOYLE M JONES K HUDSON A JAMES AJ SHORE A HIGHAM A MARTIN B NEIL HAW BUTTERFIELD WJH DOLL WRS EASTMAN R FERRIS FR KURINIJ N MCPHERSON K MAHLER RF MEADE TW SHAFER G WATKINS PJ KEEN H SIEGEL D WRIGHT AD BETTERIDGE DJ COHEN RD CURRIE D DARBYSHIRE J FORRESTER JV GUPPY T JOHNSTON DG MCGUIRE A MURPHY M ELNAHAS AM PENTECOST B SPIEGELHALTER D ALBERTI KGMM DENTON R HOME PD HOWELL S JARRETT JR MARKS V MARMOT M WARD JD
Citation: Rc. Turner et al., INTENSIVE BLOOD-GLUCOSE CONTROL WITH SULFONYLUREAS OR INSULIN COMPARED WITH CONVENTIONAL TREATMENT AND RISK OF COMPLICATIONS IN PATIENTS WITH TYPE-2 DIABETES (UKPDS-33), Lancet, 352(9131), 1998, pp. 837-853
THE EFFECTS OF BRIEF EXPOSURE AND OF CLASSROOM TEACHING ON ATTITUDES CHILDREN EXPRESS TOWARDS FACIAL DISFIGUREMENT IN PEERS
Authors: CLINE T PROTO A RAVAL P DIPAOLO T
Citation: T. Cline et al., THE EFFECTS OF BRIEF EXPOSURE AND OF CLASSROOM TEACHING ON ATTITUDES CHILDREN EXPRESS TOWARDS FACIAL DISFIGUREMENT IN PEERS, Educational research, 40(1), 1998, pp. 55-68
COMPARISON OF THE CARDIOVASCULAR EFFECTS OF THE NOVEL 5-HT1B 1D RECEPTOR AGONIST, SB-209509 (VML251), AND SUMATRIPTAN IN DOGS/
Authors: PARSONS AA PARKER SG RAVAL P CAMPBELL CA LEWIS VA GRIFFITHS R HUNTER AJ HAMILTON TC KING FD
Citation: Aa. Parsons et al., COMPARISON OF THE CARDIOVASCULAR EFFECTS OF THE NOVEL 5-HT1B 1D RECEPTOR AGONIST, SB-209509 (VML251), AND SUMATRIPTAN IN DOGS/, Journal of cardiovascular pharmacology, 30(1), 1997, pp. 136-141
A METHOD FOR DETERMINING THERMAL HYPERALGESIA AND INFLAMMATION IN THEMOUSE HIND PAW
Authors: SAMMONS M RAVAL P BINGHAM S DAVEY P PARSONS AA
Citation: M. Sammons et al., A METHOD FOR DETERMINING THERMAL HYPERALGESIA AND INFLAMMATION IN THEMOUSE HIND PAW, British Journal of Pharmacology, 122, 1997, pp. 334-334
DETERMINATION OF HALF-LIFE FOR MESSENGER-RNA EXPRESSED IN FEW COPIES AND WITH SHORT LIFE
Authors: RAVAL P
Citation: P. Raval, DETERMINATION OF HALF-LIFE FOR MESSENGER-RNA EXPRESSED IN FEW COPIES AND WITH SHORT LIFE, Journal of pharmacological and toxicological methods, 35(1), 1996, pp. 31-34
LIPOPOLYSACCHARIDE DOWN-REGULATES IFN-GAMMA RECEPTOR (ALPHA-CHAIN) MESSENGER-RNA IN MOUSE MACROPHAGES
Authors: RAVAL P FAN F RUSSELL W
Citation: P. Raval et al., LIPOPOLYSACCHARIDE DOWN-REGULATES IFN-GAMMA RECEPTOR (ALPHA-CHAIN) MESSENGER-RNA IN MOUSE MACROPHAGES, The FASEB journal, 10(6), 1996, pp. 1687-1687
OSTEOINDUCTIVE ABILITY OF CONFLUENT SAOS-2 CELLS CORRELATES WITH ENHANCED EXPRESSION OF BONE MORPHOGENETIC PROTEINS
Authors: RAVAL P HSU HHT ANDERSON HC
Citation: P. Raval et al., OSTEOINDUCTIVE ABILITY OF CONFLUENT SAOS-2 CELLS CORRELATES WITH ENHANCED EXPRESSION OF BONE MORPHOGENETIC PROTEINS, Journal of orthopaedic research, 14(4), 1996, pp. 605-610
EXPRESSION OF BONE MORPHOGENETIC PROTEINS BY OSTEOINDUCTIVE AND NON-OSTEOINDUCTIVE HUMAN OSTEOSARCOMA CELLS
Authors: RAVAL P HSU HHT SCHNEIDER DJ SARRAS MP MASUHARA K BONEWALD LF ANDERSON HC
Citation: P. Raval et al., EXPRESSION OF BONE MORPHOGENETIC PROTEINS BY OSTEOINDUCTIVE AND NON-OSTEOINDUCTIVE HUMAN OSTEOSARCOMA CELLS, Journal of dental research, 75(7), 1996, pp. 1518-1523
COMPARISON OF THE CARDIOVASCULAR EFFECTS OF SB-209509 (VML-251) AND SUMATRIPTAN IN DOGS
Authors: PARSONS AA PARKER SG RAVAL P CAMPBELL CA HUNTER AJ HAMILTON TC KING FD
Citation: Aa. Parsons et al., COMPARISON OF THE CARDIOVASCULAR EFFECTS OF SB-209509 (VML-251) AND SUMATRIPTAN IN DOGS, British Journal of Pharmacology, 119, 1996, pp. 109-109
SB-209509 (VML-251), A POTENT CONSTRICTOR OF RABBIT BASILAR ARTERY WITH HIGH-AFFINITY AND SELECTIVITY FOR HUMAN 5-HT1D RECEPTORS
Authors: BROWN AM PARSONS AA RAVAL P PORTER R TILFORD NS GAGER TL PRICE GW WOOD MD KAUMANN AJ YOUNG RA RANA K WARRINGTON BH KING FD
Citation: Am. Brown et al., SB-209509 (VML-251), A POTENT CONSTRICTOR OF RABBIT BASILAR ARTERY WITH HIGH-AFFINITY AND SELECTIVITY FOR HUMAN 5-HT1D RECEPTORS, British Journal of Pharmacology, 119, 1996, pp. 110-110
A COMPARISON OF THE AGONIST PROFILE OF SB-209509 (VML-251) AND SUMATRIPTAN IN HUMAN ISOLATED BASILAR AND CORONARY-ARTERIES
Authors: RAVAL P TILFORD NS SMITH SJ PORTER R KING FD KAUMANN AJ HUNER AJ PARSONS AA
Citation: P. Raval et al., A COMPARISON OF THE AGONIST PROFILE OF SB-209509 (VML-251) AND SUMATRIPTAN IN HUMAN ISOLATED BASILAR AND CORONARY-ARTERIES, British Journal of Pharmacology, 119, 1996, pp. 111-111
ENHANCED EXPRESSION OF BONE MORPHOGENETIC PROTEINS IN CONFLUENT SAOS-2 CELLS CORRELATES WITH OSTEOINDUCTIVITY
Authors: RAVAL P ANDERSON HC
Citation: P. Raval et Hc. Anderson, ENHANCED EXPRESSION OF BONE MORPHOGENETIC PROTEINS IN CONFLUENT SAOS-2 CELLS CORRELATES WITH OSTEOINDUCTIVITY, Journal of bone and mineral research, 10, 1995, pp. 233-233
CHARACTERIZATION OF THE 5'-FLANKING REGION AND GENE ENCODING THE MOUSE INTERFERON-GAMMA RECEPTOR
Authors: RAVAL P OBICI S RUSSELL SW MURPHY WJ
Citation: P. Raval et al., CHARACTERIZATION OF THE 5'-FLANKING REGION AND GENE ENCODING THE MOUSE INTERFERON-GAMMA RECEPTOR, Gene, 154(2), 1995, pp. 219-223
THE MECHANISM OF BONE INDUCTION AND BONE HEALING BY HUMAN OSTEOSARCOMA CELL-EXTRACTS
Authors: ANDERSON HC HSU HHT RAVAL P HUNT TR SCHWAPPACH JR MORRIS DC SCHNEIDER DJ
Citation: Hc. Anderson et al., THE MECHANISM OF BONE INDUCTION AND BONE HEALING BY HUMAN OSTEOSARCOMA CELL-EXTRACTS, Clinical orthopaedics and related research, (313), 1995, pp. 129-134
QUALITATIVE AND QUANTITATIVE-DETERMINATION OF MESSENGER-RNA
Authors: RAVAL P
Citation: P. Raval, QUALITATIVE AND QUANTITATIVE-DETERMINATION OF MESSENGER-RNA, Journal of pharmacological and toxicological methods, 32(3), 1994, pp. 125-127
TOLERANCE TO PERIPHERAL, BUT NOT CENTRAL, EFFECTS OF ROPINIROLE, A SELECTIVE DOPAMINE D-2-LIKE RECEPTOR AGONIST
Authors: PARKER SG RAVAL P YEULET S EDEN RJ
Citation: Sg. Parker et al., TOLERANCE TO PERIPHERAL, BUT NOT CENTRAL, EFFECTS OF ROPINIROLE, A SELECTIVE DOPAMINE D-2-LIKE RECEPTOR AGONIST, European journal of pharmacology, 265(1-2), 1994, pp. 17-26
MACROPHAGE NITRIC-OXIDE SYNTHASE GENE - 2 UPSTREAM REGIONS MEDIATE INDUCTION BY INTERFERON-GAMMA AND LIPOPOLYSACCHARIDE
Authors: LOWENSTEIN CJ ALLEY EW RAVAL P SNOWMAN AM SNYDER SH RUSSELL SW MURPHY WJ
Citation: Cj. Lowenstein et al., MACROPHAGE NITRIC-OXIDE SYNTHASE GENE - 2 UPSTREAM REGIONS MEDIATE INDUCTION BY INTERFERON-GAMMA AND LIPOPOLYSACCHARIDE, Proceedings of the National Academy of Sciences of the United Statesof America, 90(20), 1993, pp. 9730-9734
)3-AMINO-6-CARBOXAMIDO-1,2,3,4-TETRAHYDROCARBAZOLE - A CONFORMATIONALLY RESTRICTED ANALOG OF 5-CARBOXAMIDOTRYPTAMINE WITH SELECTIVITY FOR THE SEROTONIN 5-HT1D RECEPTOR (VOL 36, PG 1919, 1993)
Authors: KING FD BROWN AM GASTER LM KAUMANN AJ MEDHURST AD PARKER SG PARSONS AA PATCH TL RAVAL P
Citation: Fd. King et al., )3-AMINO-6-CARBOXAMIDO-1,2,3,4-TETRAHYDROCARBAZOLE - A CONFORMATIONALLY RESTRICTED ANALOG OF 5-CARBOXAMIDOTRYPTAMINE WITH SELECTIVITY FOR THE SEROTONIN 5-HT1D RECEPTOR (VOL 36, PG 1919, 1993), Journal of medicinal chemistry, 36(21), 1993, pp. 3218-3218
(+ -) 3-AMINO-6-CARBOXAMIDO-1,2,3,4-TETRAHYDROCARBAZOLE - A CONFORMATIONALLY RESTRICTED ANALOG OF 5-CARBOXAMIDOTRYPTAMINE WITH SELECTIVITY FOR THE SEROTONIN 5-HT1D RECEPTOR/
Authors: KING FD BROWN AM GASTER LM KAUMANN AJ MEDHURST AD PARKER SG PARSONS AA PATCH TL RAVAL P
Citation: Fd. King et al., (+ -) 3-AMINO-6-CARBOXAMIDO-1,2,3,4-TETRAHYDROCARBAZOLE - A CONFORMATIONALLY RESTRICTED ANALOG OF 5-CARBOXAMIDOTRYPTAMINE WITH SELECTIVITY FOR THE SEROTONIN 5-HT1D RECEPTOR/, Journal of medicinal chemistry, 36(13), 1993, pp. 1918-1919
Risultati: 1-24 |